In a recent clinical trial, some patients with type 2 diabetes showed a clinically significant reduction in blood glucose after taking an anti-asthma drug for 12 weeks. Here we talk to Alan Saltiel, PhD, who led the study, about what this drug is, why it seems to help some diabetics but not others, and how his team is working to personalize diabetes treatments.